Press release
Formulated Solutions announces 19 new business wins and expands manufacturing capabilities
Growth spans aerosols, nasal sprays, oral liquids and specialized medical device production.
Largo, Fla. · November 2, 2026
|
19
New business wins in 2026 across consumer health, pharmaceutical and medical device |
26%
Year-over-year sales growth with the company’s largest customer |
3
Capability expansions underway: nasal sprays, oral liquids and a dedicated medical device suite |
Summary
LARGO, Fla., November 2, 2026 — Formulated Solutions today announced 19 new business wins in 2026 and manufacturing capability expansions supporting its growing consumer health, pharmaceutical and medical device portfolio.
The awards add future commercialization opportunities alongside growth in established customer relationships. Sales to the company’s largest customer are currently up 26% year over year.
| 01 |
Expanding capabilitiesFormulated Solutions is increasing nasal spray production, expanding oral liquids production and advancing a dedicated production suite for a large medical device customer. These initiatives broaden its capabilities and support new programs as they move toward commercialization. Nasal spray production Oral liquids production Dedicated medical device suite |
| 02 |
Rapid growth across the aerosol portfolioThe company’s aerosol portfolio is expanding rapidly through new awards and ongoing programs across conventional aerosols, bag-on-valve systems and specialty foams, building on its experience with complex formulations and dispensing formats. Conventional aerosols Bag-on-valve systems Specialty foams |
“These wins represent an important step in the growth of Formulated Solutions. Customers are entrusting us with additional products and increasingly complex manufacturing responsibilities. We are expanding production and building the specialized capabilities needed to bring these programs to market.”
Victor Swint, Chief Executive Officer
| 03 |
Investing in infrastructure and digital systemsAdditional activity includes topical manufacturing transfers and pharmaceutical development. Investments in manufacturing infrastructure and digital production systems support these programs. |
| 04 |
Positioned for 2027 and beyondThe new awards and capability expansions position Formulated Solutions to support additional technology transfers and commercial launches in 2027 and beyond, as individual programs advance through development and commercialization. |
About Formulated Solutions
Formulated Solutions is a contract development and manufacturing organization serving OTC, prescription pharmaceutical and medical device customers. Its Largo, Florida, and Cleveland, Tennessee, operations support development through commercial manufacturing of topical liquids and semisolids, aerosols and foams, multidose nasal sprays and oral liquids.
|
Largo, Florida
Global headquarters · topicals and semisolids: aerosols, BOV, nasal sprays, tubes, liquids, and oral liquids
|
Cleveland, Tennessee
Topicals and semisolids: aerosols, BOV, tubes, and liquids
|
.png?width=1000&name=1%20%C2%B7%20Cover@2x%20(1).png)